The risk of second primary cancer after nasopharyngeal cancer: a systematic review
| dc.contributor.author | Svärd Fanni | |
| dc.contributor.author | Omobolaji Alabi Rasheed | |
| dc.contributor.author | Leivo Ilmo | |
| dc.contributor.author | Mäkitie Antti A. | |
| dc.contributor.author | Almangush Alhadi | |
| dc.contributor.organization | fi=biolääketieteen laitos|en=Institute of Biomedicine| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.77952289591 | |
| dc.converis.publication-id | 180641959 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/180641959 | |
| dc.date.accessioned | 2025-08-27T23:34:09Z | |
| dc.date.available | 2025-08-27T23:34:09Z | |
| dc.description.abstract | <p>Purpose: Second primary cancers (SPCs) after nasopharyngeal cancer (NPC) are rare, but have an impact on the follow-up of this patient population. The aim of this study is to systematically review the literature to determine the prevalence and most typical sites of SPCs after NPC. <br></p><p>Methods: We searched the databases of PubMed, Web of Science, and Scopus for articles on SPCs after NPC. The Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines were followed.<br></p><p>Results: This review includes data on 89 168 patients with NPC from 21 articles. The mean occurrence for SPCs was 6.6% and varied from 4.9% in endemic areas to 8.7% in non-endemic areas. The most frequent locations of SPCs were oral cavity, pharynx, nose and paranasal sinuses, esophagus and lung.<br></p><p>Conclusion: There is an increased risk for a SPC after NPC management, especially in non-endemic areas. However, their mean rate is lower than after other head and neck carcinomas.</p> | |
| dc.identifier.eissn | 1434-4726 | |
| dc.identifier.jour-issn | 0937-4477 | |
| dc.identifier.olddbid | 204210 | |
| dc.identifier.oldhandle | 10024/187237 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/52408 | |
| dc.identifier.url | http://dx.doi.org/10.1007%2Fs00405-023-08144-0 | |
| dc.identifier.urn | URN:NBN:fi-fe2025082786356 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Leivo, Ilmo | |
| dc.okm.affiliatedauthor | Almangush, Alhadi | |
| dc.okm.discipline | 3121 Internal medicine | en_GB |
| dc.okm.discipline | 3122 Cancers | en_GB |
| dc.okm.discipline | 3125 Otorhinolaryngology, ophthalmology | en_GB |
| dc.okm.discipline | 3121 Sisätaudit | fi_FI |
| dc.okm.discipline | 3122 Syöpätaudit | fi_FI |
| dc.okm.discipline | 3125 Korva-, nenä- ja kurkkutaudit, silmätaudit | fi_FI |
| dc.okm.internationalcopublication | international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | A2 Scientific Article | |
| dc.publisher | SPRINGER | |
| dc.publisher.country | Germany | en_GB |
| dc.publisher.country | Saksa | fi_FI |
| dc.publisher.country-code | DE | |
| dc.relation.doi | 10.1007/s00405-023-08144-0 | |
| dc.relation.ispartofjournal | European Archives of Oto-Rhino-Laryngology | |
| dc.source.identifier | https://www.utupub.fi/handle/10024/187237 | |
| dc.title | The risk of second primary cancer after nasopharyngeal cancer: a systematic review | |
| dc.year.issued | 2023 |
Tiedostot
1 - 1 / 1